Avecor to boost research and development (R&D) into disposables for bypass operations
This article was originally published in Clinica
Executive Summary
US company Avecor Cardiovascular plans to increase its R&D expenditure by at least 15% this year as it expands its line of disposable medical devices for heart/lung bypass and long-term respiratory support. R&D spend was $2.3 million in 1994, up 22% on the previous year.